Discounted Cash Flow
Oscar Health, Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2020 | $462.8m | $-406.8m | $222.7m | -87.9% | $-14.16 |
| 2021 | $1.8b (297.3%) | $-572.6m (-40.7%) | $-181.7m (-181.6%) | -31.1% (64.6%) | $-3.20 (77.4%) |
| 2022 | $61.0m (-96.7%) | $-606.3m (-5.9%) | $351.3m (293.3%) | -993.1% (-3089.1%) | $-2.85 (10.9%) |
| 2023 | $15.4m (-74.7%) | $-270.7m (55.3%) | $-297.7m (-184.7%) | -1753.2% (-76.5%) | $-1.22 (57.2%) |
| 2024 | $20.6m (33.2%) | $25.4m (109.4%) | $25.4m (108.5%) | 123.6% (107.1%) | $0.11 (109.0%) |
| 2025 | $28.6m (39.0%) | $-443.2m (-1842.5%) | $1.1b (4062.0%) | -1549.9% (-1353.9%) | $-1.69 (-1636.4%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.